Lyell Immunopharma, Inc. (LYEL)
Market Closed
3 Jun, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
12. 57
-2.32
-15.5809%
$
390.38M Market Cap
- P/E Ratio
- Div Yield
412,847 Volume
-0.85 Eps
$ 14.89
Previous Close Want to track LYEL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
LYEL Earnings Reports FAQ
What is the earnings per share (EPS) for LYEL?
The current EPS is -0.85.
What is the company's earnings growth rate?
Lyell Immunopharma, Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Lyell Immunopharma, Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Lyell Immunopharma, Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for LYEL at this time, as Lyell Immunopharma, Inc has no recent EPS data to calculate it.
